clinical pathology: bone marker
DESCRIPTION
Clinical pathology: BONE MARKER. GENERAL OBJECTIVE : After finishing lab activity of Bone Marker, the student will be able to describe the Bone Marker in the DMS case problem SPECIFIC OBJECTIVE : At the end of lab activity of Bone Marker , the student will be able to interprete: - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/1.jpg)
GENERAL OBJECTIVE: After finishing lab activity of Bone Marker, the
student will be able to describe the Bone Marker in the DMS case problem
SPECIFIC OBJECTIVE: At the end of lab activity of Bone Marker , the
student will be able to interprete: - the normal of Bone Marker - the abnormal of Bone Marker
![Page 2: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/2.jpg)
GENERAL OBJECTIVE:After finishing lab activity of bone
marker, the student will be able to describe the bone marker in the DMS
case problemSPECIFIC OBJECTIVE:
At the end of lab activity of bone marker, the student will be able to
interprete:- the normal and abnormal bone
marker
![Page 3: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/3.jpg)
organic matrix(30% )
cells(2%) Matrix (98%)
collagen tipe 1 (95%) noncollagen protein (5%)-Osteonectin
-Osteocalcin- Bone Proteoglikan - Bone morfogenik protein
-Bone proteolipid -Bone phosfolipid
inorganic matrix(70% )
-Hidroksiapatit (95%)(Ca10(PO4)6(OH)2)
- Mg, Na, K, F, Cl, Sr, Pb (5%)
BONE PHYSIOLOGY:
![Page 4: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/4.jpg)
BONE FORMATION AND RESORPTION
Bone turnover is characterized by twometabolic processes: Formation of new bone by osteoblast Degradation/resorption of old bone
by osteoclast
Bone mass depends on the balancedbetween bone formation and
resorption
![Page 5: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/5.jpg)
![Page 6: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/6.jpg)
Bone formation can be assessed by determination of: Total /Bone specific alkaline phosphatase and osteocalcin
Bone resorption can be assessed by determination of pyridinoline, cross linked N telopeptide and C terminal telopeptide (-crosslaps)
![Page 7: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/7.jpg)
Osteocalcin
![Page 8: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/8.jpg)
The most important non-collagen protein (Bone specific peptide)
Synthesize by osteoblast (marker bone turnover)
After release from osteoblast, assimilated into bone matrix and also secreted to the bloodstream
![Page 9: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/9.jpg)
Specimen: serum or plasma Reference range: Male 18 - < 30 years: 24 – 70 ng/mL 30 - 50 years: 14 – 42 ng/mL >50 - 70 years: 14 – 46 ng/mL Female Premenopause> 20 years: 11 – 43
ng/mL Postmenopause : 15 – 46
ng/mL
![Page 10: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/10.jpg)
Crosslaps
![Page 11: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/11.jpg)
The specific degraded product of type 1 collagen (the C terminal telopeptides)
Increased bone resorption will cause the elevation of -crosslaps in serum
![Page 12: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/12.jpg)
![Page 13: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/13.jpg)
Specimen: serum Reference range: Male 30 - 70 years: 0.016 – 0.584 ng/mL >70years : 0.104 – 0.854
ng/mL Female Premenopause : 0.025 – 0.573 ng/mL Postmenopause : 0.104 – 1. 008 ng/mL
![Page 14: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/14.jpg)
![Page 15: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/15.jpg)
An enzyme located in osteoblast, liver , intestine, kidney and placenta
Function: activate the chemical reaction in in cells which the enzyme located
High concentration of ALP → specific organ has increased the production or release this enzyme ( bone or liver)
The causes of elevated ALP from bone disease → no elevation of ALT or AST
![Page 16: Clinical pathology: BONE MARKER](https://reader036.vdocuments.net/reader036/viewer/2022081421/568145e5550346895db2e58d/html5/thumbnails/16.jpg)
Specimen: serum Reference range: 370C Male < 129 U/L Female < 104 U/L Children higher (depends on age)